<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01443559</url>
  </required_header>
  <id_info>
    <org_study_id>EIXM-XKFPC-20110901</org_study_id>
    <nct_id>NCT01443559</nct_id>
  </id_info>
  <brief_title>Xenogenic Keratoplasty From Porcine Cornea</brief_title>
  <acronym>XKFPC</acronym>
  <official_title>Phase I Study of Xenogenic Keratoplasty From Porcine Cornea in the Treatment of Infectious Corneal Ulcer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiamen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xiamen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acellular porcine cornea is a valid substitution for human cornea because of its similar&#xD;
      biological structure, corneal superficial curvature and good histocompatibility toward human.&#xD;
      Facing the lack of human cornea donor, it is hypothesised that using acellular lamellar&#xD;
      porcine cornea as an alternative of lamellar human cornea to treat infectious corneal ulcer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acellular porcine cornea eligibility criteria:&#xD;
&#xD;
        1. fresh porcine cornea,&#xD;
&#xD;
        2. porcine cornea keeping transparent without scar, neovascularization or corneal ulcer,&#xD;
&#xD;
        3. porcine cornea keeping integrative corneal epithelium and endothelium,&#xD;
&#xD;
        4. acellular porcine cornea keeping transparent.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    there was not enough patients recruited in this study&#xD;
  </why_stopped>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of rejection in three months after keratoplasty</measure>
    <time_frame>three months after lamellar keratoplasty</time_frame>
    <description>Rate of epithelium rejection Epithelial rejection performances: 1.1 epithelium edema, OR 1.2 epithelium opacity, OR 1.3 epithelial rejection line.&#xD;
Rate of stroma rejection Stroma rejection performances: 2.1 stroma edema, OR 2.2 stroma opacity, OR 2.3 suture loosing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Density of regenerative sub-epithelial nerve plex, stromal nerve and stromal keratocytes in vivo confocal microscopy</measure>
    <time_frame>one year</time_frame>
    <description>Shapes and location:&#xD;
Sub-epithelial nerve plex is in the depth between 35um to 65um shaping like white thin line with branches in vivo confocal microscopy.&#xD;
Sromal nerve is in the stromal layer(about 70um to 500um) shaping like white thick trunk with branches in vivo confocal microscopy.&#xD;
Stromal keratocytes is in the stromal layer like white rod-shape in vivo confocal microscopy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Porcine Corneal Xenograph</condition>
  <arm_group>
    <arm_group_label>Xenogenic cornea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>human cornea</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Xenogenic cornea</intervention_name>
    <description>lamellar acellular xenogenic corneas were sterilised by radiation</description>
    <arm_group_label>Xenogenic cornea</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>homogenic cornea</intervention_name>
    <description>homogenic corneas were sterilised by radiation</description>
    <arm_group_label>human cornea</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with severe infectious corneal ulcer&#xD;
&#xD;
          -  The ulcers can not be controlled with existing antibiotics eye drops or medicine after&#xD;
             1 week treatment&#xD;
&#xD;
          -  The infected corneas have risks of penetrating&#xD;
&#xD;
          -  The depth of ulcers are less than 400um&#xD;
&#xD;
          -  The bridge of the ulcers is away from corneal limbal more than 1mm&#xD;
&#xD;
          -  Patients aged 18 or older&#xD;
&#xD;
          -  Patients able and willing to sign the informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with severe infectious corneal ulcer in stable stage&#xD;
&#xD;
          -  Patients with corneal ulcers after viruses infection, such as herpes simplex virus&#xD;
&#xD;
          -  Patients with corneal ulcers from non-infectious factors, such as toxicity, burn or&#xD;
             immunological inflammation&#xD;
&#xD;
          -  The ulcers are not cover pupil zone and will not result in visional defect in future&#xD;
&#xD;
          -  The depth of ulcer is less than 50um&#xD;
&#xD;
          -  Patients has history of keratoplasty surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zuguo Liu, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Eye Institute of Xiamen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xiamen University Affiliated Xiamen Eye Center</name>
      <address>
        <city>Xiamen</city>
        <state>Fujian</state>
        <zip>361005</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>September 19, 2011</study_first_submitted>
  <study_first_submitted_qc>September 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2011</study_first_posted>
  <last_update_submitted>July 16, 2015</last_update_submitted>
  <last_update_submitted_qc>July 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xiamen University</investigator_affiliation>
    <investigator_full_name>Zuguo Liu</investigator_full_name>
    <investigator_title>Dean of Xiamen University Medical School</investigator_title>
  </responsible_party>
  <keyword>Xenogenic</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

